business
CVC and GBL Propose $12 Billion Acquisition of Italy's Recordati

CVC and GBL Propose $12 Billion Acquisition of Italy's Recordati

22 Mayıs 2026Bloomberg
  • CVC Capital Partners Plc and Groupe Bruxelles Lambert have made a significant offer to acquire Recordati SpA, an Italian pharmaceutical company, for over $12 billion. This potential acquisition is poised to be one of the largest healthcare transactions in Europe for the year.
  • The deal highlights the ongoing consolidation in the healthcare sector as firms seek to expand their portfolios.
  • The healthcare sector has seen a flurry of mergers and acquisitions as companies look to leverage synergies and expand their market presence. With this offer, CVC and GBL are positioning themselves to capitalize on Recordati's established market presence and product portfolio, which could enhance their competitive e…
  • The proposed acquisition of Recordati by CVC and GBL underscores the growing trend of private equity firms targeting established pharmaceutical companies. This move not only reflects confidence in the pharmaceutical sector's resilience but also indicates a strategic shift towards diversifying investments in healthca…
NewsAI özeti

This article is for informational purposes only and does not constitute investment advice.